Citrobacter infections in a general hospital: Characteristics and outcomes

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 1, 2009, Pages 61-68

  Samonis, G ^a   Karageorgopoulos, D E ^b   Kofteridis, D P ^a,b   Matthaiou, D K ^b   Sidiropoulou, V ^a   Maraki, S ^a   Falagas, M E ^b,c,d  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c HENRY DUNANT HOSPITAL   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMAZINE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BACTERIURIA; CITROBACTER; CITROBACTER BRAAKII; CITROBACTER FREUNDII; CITROBACTER KOSERI; CONTROLLED STUDY; FEMALE; GENERAL HOSPITAL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEPTIC SHOCK; SKIN INFECTION; SOFT TISSUE INFECTION; TERTIARY HEALTH CARE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ABDOMINAL ABSCESS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CITROBACTER; COHORT STUDIES; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS, GENERAL; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; SURGICAL WOUND INFECTION; URINARY TRACT INFECTIONS;

EID: 58149145766     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0598-z     Document Type: Article

References (27)

1. JM Janda SL Abbott WK Cheung DF Hanson 1994 Biochemical identification of citrobacteria in the clinical laboratory J Clin Microbiol 32 1850 1854
2. DJ Brenner CM O'Hara PA Grimont JM Janda E Falsen E Aldova 1999 Biochemical identification of Citrobacter species defined by DNA hybridization and description of Citrobacter gillenii sp. nov. (formerly Citrobacter genomospecies 10) and Citrobacter murliniae sp. nov. (formerly Citrobacter genomospecies 11) J Clin Microbiol 37 2619 2624
3. GR Hodges CE Degener WG Barnes 1978 Clinical significance of citrobacter isolates Am J Clin Pathol 70 37 40
4. BA Lipsky EW Hook 3rd AA Smith JJ Plorde 1980 Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature Rev Infect Dis 2 746 760
5. JP Lavigne C Defez N Bouziges A Mahamat A Sotto 2007 Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital Eur J Clin Microbiol Infect Dis 26 439 441
6. S Mohanty R Singhal S Sood B Dhawan A Kapil BK Das 2007 Citrobacter infections in a tertiary care hospital in Northern India J Infect 54 58 64
7. S Arens L Verbist 1997 Differentiation and susceptibility of Citrobacter isolates from patients in a university hospital Clin Microbiol Infect 3 53 57
8. C Pepperell JV Kus MA Gardam A Humar LL Burrows 2002 Low-virulence Citrobacter species encode resistance to multiple antimicrobials Antimicrob Agents Chemother 46 3555 3560
9. G Altmann I Sechter D Cahan CB Gerichter 1976 Citrobacter diversus isolated from clinical material J Clin Microbiol 3 390 392
10. G Samonis E Anaissie L Elting GP Bodey 1991 Review of Citrobacter bacteremia in cancer patients over a sixteen-year period Eur J Clin Microbiol Infect Dis 10 479 485
11. TI Doran 1999 The role of Citrobacter in clinical disease of children: review Clin Infect Dis 28 384 394
12. RN Jones SG Jenkins DJ Hoban MA Pfaller R Ramphal 2000 In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998 Int J Antimicrob Agents 15 111 118
13. N Gupta A Yadav U Choudhary DR Arora 2003 Citrobacter bacteremia in a tertiary care hospital Scand J Infect Dis 35 765 768
14. M Barlow BG Hall 2002 Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii Antimicrob Agents Chemother 46 1190 1198
15. Horan TC, Gaynes RP (2004) Surveillance of nosocomial infections. In: Mayhall CG (eds) Hospital epidemiology and infection control, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1659-1702
16. ME Falagas PK Kavvadia E Mantadakis DP Kofteridis IA Bliziotis E Saloustros 2006 Morganella morganii infections in a general tertiary hospital Infection 34 315 321
17. CC Shih YC Chen SC Chang KT Luh WC Hsieh 1996 Bacteremia due to Citrobacter species: significance of primary intraabdominal infection Clin Infect Dis 23 543 549
18. BN Kim JH Woo J Ryu YS Kim 2003 Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia Infection 31 202 207
19. BN Fields MM Uwaydah LJ Kunz MN Swartz 1967 The so-called "Paracolon" bacteria. A bacteriologic and clinical reappraisal Am J Med 42 89 106
20. YS Chen WW Wong CP Fung KW Yu CY Liu 2002 Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia J Microbiol Immunol Infect 35 109 114
21. V Drelichman JD Band 1985 Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome Arch Intern Med 145 1808 1810
22. G Samonis DH Ho GF Gooch KV Rolston GP Bodey 1987 In vitro susceptibility of Citrobacter species to various antimicrobial agents Antimicrob Agents Chemother 31 829 830
23. JT Wang SC Chang YC Chen KT Luh 2000 Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods J Microbiol Immunol Infect 33 258 262
24. ME Falagas SK Kasiakou 2005 Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin Infect Dis 40 1333 1341
25. P Nordmann 1998 Trends in beta-lactam resistance among Enterobacteriaceae Clin Infect Dis 27 Suppl 1 S100 S106
26. YJ Park SY Park EJ Oh JJ Park KY Lee GJ Woo 2005 Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria Diagn Microbiol Infect Dis 51 265 269
27. BN Kim SO Lee SH Choi NJ Kim JH Woo J Ryu 2003 Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species Int J Antimicrob Agents 22 106 111